Cargando…

Hepatoma-derived growth factor predicts unfavorable prognosis of epithelial ovarian cancer

AIM: To evaluate the expression and clinical significance of hepatoma-derived growth factor (HDGF) in epithelial ovarian cancer (EOC). BACKGROUND: Recent studies have demonstrated that HDGF overexpression correlates to the progression and poor prognosis in several kinds of cancers. However, the clin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Xue-jun, Liu, Wen-lian, Yang, Fang-mei, Yang, Xiao-qing, Lu, Xiao-fei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4540117/ https://www.ncbi.nlm.nih.gov/pubmed/26316779 http://dx.doi.org/10.2147/OTT.S85660

Ejemplares similares

Hepatoma-derived growth factor functions as an unfavorable prognostic marker of human gliomas
por: Yang, Yang, et al.
Publicado: (2017)

Low FOXJ2 expression is associated with unfavorable postoperative prognosis of patients with epithelial ovarian cancer
por: Li, Yong, et al.
Publicado: (2021)

High Expression of RING Finger Protein 126 Predicts Unfavorable Prognosis of Epithelial Ovarian Cancer
por: Wang, Chuanjiang, et al.
Publicado: (2020)

Stonin 2 Overexpression is Correlated with Unfavorable Prognosis and Tumor Invasion in Epithelial Ovarian Cancer
por: Sun, Xiaoying, et al.
Publicado: (2017)

Upregulation of centrosomal protein 55 is associated with unfavorable prognosis and tumor invasion in epithelial ovarian carcinoma
por: Zhang, Weijing, et al.
Publicado: (2015)

Long non-coding RNA taurine-upregulated gene 1 predicts unfavorable prognosis, promotes cells proliferation, and inhibits cells apoptosis in epithelial ovarian cancer
por: Li, Tong-Huai, et al.
Publicado: (2018)

CBX3 predicts an unfavorable prognosis and promotes tumorigenesis in osteosarcoma
por: Ma, Chao, et al.
Publicado: (2019)

Overexpression of long noncoding RNA HOXB-AS3 indicates an unfavorable prognosis and promotes tumorigenesis in epithelial ovarian cancer via Wnt/β-catenin signaling pathway
por: Zhuang, Xiao-hong, et al.
Publicado: (2019)

Increased expression of Na(+)/H(+) exchanger isoform 1 predicts tumor aggressiveness and unfavorable prognosis in epithelial ovarian cancer
por: Wang, Haixia, et al.
Publicado: (2018)

Omental metastasis as a predictive risk factor for unfavorable prognosis in patients with stage III–IV epithelial ovarian cancer
por: Iwagoi, Yutaka, et al.
Publicado: (2021)

Downregulated expression of CFHL1 is associated with unfavorable prognosis in postoperative patients with hepatocellular carcinoma
por: Feng, Hao, et al.
Publicado: (2019)

A novel nomogram based on LODDS to predict the prognosis of epithelial ovarian cancer
por: Xu, Xue-Lian, et al.
Publicado: (2016)

PD-L1 Expression On tumor Cells Was Associated With Unfavorable Prognosis In Esophageal Squamous Cell Carcinoma
por: Wang, Qiao, et al.
Publicado: (2018)

Overexpression of WWP1 Promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma
por: Zhang, Xiao-Fei, et al.
Publicado: (2015)

LSINCT5 predicts unfavorable prognosis and exerts oncogenic function in osteosarcoma
por: He, Weidong, et al.
Publicado: (2019)

Cytochrome 4Z1 Expression Connotes Unfavorable Prognosis in Ovarian Cancers
por: Al-saraireh, Yousef M., et al.
Publicado: (2022)

Tumor-associated lymphangiogenesis predicts unfavorable prognosis of intrahepatic cholangiocarcinoma
por: Sha, Meng, et al.
Publicado: (2019)

Loss of GFAT1 promotes epithelial-to-mesenchymal transition and predicts unfavorable prognosis in gastric cancer
por: Duan, Fangfang, et al.
Publicado: (2016)

Unfavorable prognosis of nephroblastoma in adults
por: Huszno, Joanna, et al.
Publicado: (2013)

Galectin-9 and PSMB8 overexpression predict unfavorable prognosis in patients with AML
por: Zhang, Yongping, et al.
Publicado: (2021)

Overexpression of BCCIP predicts an unfavorable prognosis and promotes the proliferation and migration of lung adenocarcinoma
por: Shi, Jie, et al.
Publicado: (2021)

Up-Regulation of Hepatoma-Derived Growth Factor Facilities Tumor Progression in Malignant Melanoma
por: Tsai, Han-En, et al.
Publicado: (2013)

Down-regulated miR-22 as predictive biomarkers for prognosis of epithelial ovarian cancer
por: Wan, Wei-na, et al.
Publicado: (2014)

Elevated expression of growth-regulated oncogene-alpha in tumor and stromal cells predicts unfavorable prognosis in pancreatic cancer
por: Lian, Shuijin, et al.
Publicado: (2016)

The HSP70 gene predicts prognosis and response to chemotherapy in epithelial ovarian cancer
por: Li, Xiao-Fei, et al.
Publicado: (2021)

Positive feedback loop of hepatoma-derived growth factor and β-catenin promotes carcinogenesis of colorectal cancer
por: Lian, Jiayan, et al.
Publicado: (2015)

Highly expressed carbohydrate sulfotransferase 11 correlates with unfavorable prognosis and immune evasion of hepatocellular carcinoma
por: Xiong, Dan‐dan, et al.
Publicado: (2022)

Mitotic phosphorylation activates hepatoma-derived growth factor as a mitogen
por: Everett, Allen D, et al.
Publicado: (2011)

Hepatoma-Derived Growth Factor and DDX5 Promote Carcinogenesis and Progression of Endometrial Cancer by Activating β-Catenin
por: Liu, Chunhua, et al.
Publicado: (2019)

Increased fibrillarin expression is associated with tumor progression and an unfavorable prognosis in hepatocellular carcinoma
por: Zhang, Jing, et al.
Publicado: (2021)

Correction: Up-Regulation of Hepatoma-Derived Growth Factor Facilities Tumor Progression in Malignant Melanoma
por: Tsai, Han-En, et al.
Publicado: (2013)

OLFML2A Overexpression Predicts an Unfavorable Prognosis in Patients with AML
por: Lu, Xuan, et al.
Publicado: (2023)

The regulatory role of hepatoma-derived growth factor as an angiogenic factor in the eye
por: LeBlanc, Michelle E., et al.
Publicado: (2016)

Gastrointestinal Symptoms Associated With Unfavorable Prognosis of COVID-19 Patients: A Retrospective Study
por: Chen, Rong, et al.
Publicado: (2020)

Actin‐like 6A predicts poor prognosis of hepatocellular carcinoma and promotes metastasis and epithelial‐mesenchymal transition
por: Xiao, Shuai, et al.
Publicado: (2016)

Reduced expression of microRNA-100 confers unfavorable prognosis in patients with bladder cancer
por: Wang, Sheng, et al.
Publicado: (2012)

Increased Expression of NXPH4 Correlates with Immune Cell Infiltration and Unfavorable Prognosis in Hepatocellular Carcinoma
por: Tang, Qin, et al.
Publicado: (2022)

Hepatoma-Derived Growth Factor: Its Possible Involvement in the Progression of Hepatocellular Carcinoma
por: Enomoto, Hirayuki, et al.
Publicado: (2015)

NAP1L1 Functions as a Tumor Promoter via Recruiting Hepatoma-Derived Growth Factor/c-Jun Signal in Hepatocellular Carcinoma
por: Zhang, Ye-wei, et al.
Publicado: (2021)

Hepatoma-derived growth factor and its role in keloid pathogenesis
por: Ooi, BNS, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_g2ai1pqnp64hpfiprv6g73lupo